SCHEMBL7340177

SCHEMBL7340177

CC[C@H](C)[C@H](NCC(=O)c1nc2ccccc2[nH]1)C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.48
DAGLA Q9Y4D2 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 6/20 0.41
KDM4E B2RXH2 2/20 0.41
HTT P42858 1/20 0.41
SMYD3 Q9H7B4 2/20 0.41
XDH P47989 2/20 0.41
CYP3A4 P08684 1/20 0.40
KMT2A Q03164 5/20 0.40
MEN1 O00255 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7340481 0.90 MPO (0.51) MPODAGLASMN1; SMN2LMNARAB9A
SCHEMBL7290997 0.81 PKM (0.49) SMN1; SMN2LMNARAB9AMAPTKDM4E
Hydrochloric Acid SCHEMBL7300661 0.81 PKM (0.51) SMN1; SMN2LMNARAB9AMAPTKDM4E
SCHEMBL7300983 0.76 PKM (0.48) SMN1; SMN2LMNARAB9AMAPTKDM4E
SCHEMBL7294735 0.73 DAGLA (0.46) MPODAGLASMN1; SMN2LMNARAB9A
SCHEMBL1901781 0.73 SMN1; SMN2 (0.61) DAGLASMN1; SMN2LMNARAB9AMAPT
SCHEMBL30831206 0.73 SMN1; SMN2 (0.61) DAGLASMN1; SMN2LMNARAB9AMAPT
SCHEMBL1735989 0.70 MAPT (0.55) DAGLASMN1; SMN2LMNARAB9AMAPT
SCHEMBL25789987 0.70 HTT (0.66) SMN1; SMN2LMNARAB9AMAPTKDM4E
SCHEMBL27203418 0.70 DAGLA (0.57) DAGLASMN1; SMN2LMNARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0492136-A2 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene AMERICAN CYANAMID COMPANY (US) 1992-07-01 EP disclosed